Halozyme Therapeutics (HALO) Wānana Kūʻai Kūʻai
Halozyme Therapeutics
Kaʻu kumukūʻai hope$113.91Hoʻohou ʻia 25 Kep. 2026 19:59 UTC
Hoʻololi-1.14%
Hōʻoia AI: HALO
Hoʻopuka ka AI i kahi kumukūʻai pahuhopu no ka lā kālepa aʻe, ka hopena pule a me ka hopena mahina. Hoʻomākaukau ʻia ka hoʻololi mai ka kumukūʻai hou loa. He helnau kūlana helu wale nō kēia, ʻaʻole he ʻōlelo aʻoaʻo hoʻopukapuka.
Kumukūʻai ma luna o nā mahina 6 i hala
Hōʻike ʻo Premium i nā pahuhopu kumukūʻai o ka AI no 1 lā, 1 pule a me 1 mahina no kēia a me nā stock ʻē aʻe.
Wehe iā Premium🔒 Moʻolelo hōʻike wānana
The forecast track record — every past forecast next to the actual close — is part of Premium.
Wehe iā PremiumE pili ana i kēia Hui
Halozyme Therapeutics, Inc. is a biopharmaceutical company that produces treatments for diabetes, cancer, and skin diseases. The company focuses on developing new drug delivery methods. Its technology platform is based on recombinant human hyaluronidase and additional enzymes.
